Treatment of acute disseminated encephalomyelitis

Current Treatment Options in Neurology

Volumn 14, Issue 3, 2012, Pages 264-275

  Pohl, Daniela ^a   Tenembaum, Silvia ^b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b Hospital de Pediatria SAMIC Prof Dr Juan P Garrahan   (Argentina)

Author keywords

Acquired demyelinating syndrome; Acute disseminated encephalomyelitis; ADEM; ADS; Adults; Childhood; Children; Corticosteroids; Diagnosis; IBD; Inflammatory brain disease; Intravenous immunoglobulin; IVIG; Management; Methylprednisolone; MRI; Multiple sclerosis; Neuromyelitis optica; NMO; Pediatric; Plasma exchange; Plasmapheresis; PLEX; Therapy; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; OLIGOCLONAL BAND; PREDNISOLONE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUTE DISSEMINATED ENCEPHALOMYELITIS; ACUTE KIDNEY FAILURE; ACUTE LUNG INJURY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; AMENORRHEA; ANAPHYLAXIS; ANEMIA; ANGIONEUROTIC EDEMA; ANOREXIA; ARTHROPATHY; ASEPTIC MENINGITIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNITY; BACKACHE; BLADDER DISEASE; BLADDER FIBROSIS; BLEEDING TENDENCY; BRAIN INFECTION; BRAIN PSEUDOTUMOR; CATARACT; CATHETER INFECTION; CATHETER THROMBOSIS; CEREBROSPINAL FLUID ANALYSIS; CHEST TIGHTNESS; CHILL; CLINICAL EXAMINATION; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONVULSION; COUGHING; DECOMPRESSIVE CRANIECTOMY; DIAGNOSTIC ACCURACY; DIARRHEA; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM INJURY; DISEASE COURSE; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG COST; DRUG ERUPTION; DRUG FATALITY; DRUG HYPERSENSITIVITY; EDEMA; EPIDURAL HEMATOMA; ERYTHEMA MULTIFORME; EVIDENCE BASED MEDICINE; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FEVER; FIBROSING ALVEOLITIS; FLUID RETENTION; FLUSHING; FOLLOW UP; GLAUCOMA; GLUCOSE INTOLERANCE; GROWTH RETARDATION; HEADACHE; HEALTH CARE COST; HEART ARREST; HEART ARRHYTHMIA; HEMOLYTIC ANEMIA; HEMORRHAGIC CYSTITIS; HIRSUTISM; HUMAN; HYDROCEPHALUS; HYPERGLYCEMIA; HYPERHIDROSIS; HYPERPROTEINEMIA; HYPERTENSION; HYPOCALCEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; IMMUNE DEFICIENCY; INAPPROPRIATE VASOPRESSIN SECRETION; INCREASED APPETITE; INFECTION; INFERTILITY; INJECTION SITE REACTION; INSOMNIA; INTRACRANIAL HYPERTENSION; INTRAOCULAR PRESSURE; KAPOSI SARCOMA; KIDNEY DYSFUNCTION; LEUKOPENIA; LIFESTYLE MODIFICATION; LIQUORRHEA; LUNG EDEMA; MEDICAL DECISION MAKING; MENSTRUAL IRREGULARITY; MENTAL DISEASE; MENTAL INSTABILITY; MULTIPLE SCLEROSIS; MUSCLE CRAMP; MYELOOPTIC NEUROPATHY; MYOCARDITIS; MYOPATHY; NAUSEA; NAUSEA AND VOMITING; NEPHROSIS; NEPHROTOXICITY; NEUROLOGIC DISEASE; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; OSTEOPOROSIS; PANCREATITIS; PARESTHESIA; PHYSIOTHERAPY; PLASMAPHERESIS; POSTOPERATIVE INFECTION; PSEUDOHYPONATREMIA; PSYCHOSIS; RELAPSE; REVIEW; RIGOR; SECOND CANCER; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; SKIN ATROPHY; SODIUM RETENTION; SPEECH DISORDER; SPEECH THERAPY; STEVENS JOHNSON SYNDROME; STOMATITIS; SUBDURAL HEMATOMA; SYNCOPE; TENDON RUPTURE; THROMBOCYTOPENIA; THROMBOEMBOLISM; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; URTICARIA; VASCULITIS; VERTIGO; VIRUS INFECTION; WEIGHT GAIN;

EID: 84865690078     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-012-0170-0     Document Type: Review

References (100)

1. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68(16 Suppl 2): S7-12.
2. Zettl UK, Stuve O, Patejdl R. Immune-mediated CNS diseases: A review on nosological classification and clinical features. Autoimmun Rev. 2012;11(3):167-73.
3. Pohl D. Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions. Curr Opin Neurol. 2008;21(3):366-72. (Pubitemid 351653990)
4. Palace J. Acute disseminated encephalomyelitis and its place amongst other acute inflammatory demyelinating CNS disorders. J Neurol Sci. 2011;306 (1-2):188-91.
5. Young NP, Weinshenker BG, Parisi JE, Scheithauer B, Giannini C, Roemer SF, et al. Perivenous demyelination: Association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain 2010 Feb;133(Pt 2):333-48. This is the first study comparing pathologic findings in ADEM and MS patients using the International Pediatric MS Study Group ADEM criteria. The criteria were shown to be 80% sensitive and 91% specific for pathologically defined ADEM.
6. Wingerchuk DM, Lucchinetti CF. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol. 2007;20 (3):343-50. (Pubitemid 46743119)
7. Marchioni E, Ravaglia S, Piccolo G, Furione M, Zardini E, Franciotta D, et al. Postinfectious inflammatory disorders: Subgroups based on prospective follow-up. Neurology. 2005;65(7):1057-65. (Pubitemid 41429631)
8. Schwarz S, Mohr A, Knauth M, Wildemann B, Storch- Hagenlocher B. Acute disseminated encephalomyelitis: A follow-up study of 40 adult patients. Neurology. 2001;56(10):1313-8. (Pubitemid 32455290)
9. Lin CH, Jeng JS, Hsieh ST, Yip PK, Wu RM. Acute disseminated encephalomyelitis: A follow-up study in Taiwan. J Neurol Neurosurg Psychiatry. 2007;78 (2):162-7.
10. Pohl D, Hennemuth I, von Kries R, Hanefeld F. Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: Results of a nationwide survey. Eur J Pediatr. 2007;166(5):405-12. (Pubitemid 46450472)
11. Leake JA, Albani S, Kao AS, Senac MO, Billman GF, Nespeca MP, et al. Acute disseminated encephalomyelitis in childhood: Epidemiologic, clinical and laboratory features. Pediatr Infect Dis J. 2004;23 (8):756-64. (Pubitemid 39063291)
12. Torisu H, Kira R, Ishizaki Y, Sanefuji M, Yamaguchi Y, Yasumoto S, et al. Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan. Brain Dev. 2010;32 (6):454-62.
13. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients. Neurology. 2002;59 (8):1224-31. (Pubitemid 35192393)
14. Banwell B, Kennedy J, Sadovnick D, Arnold DL, Magalhaes S, Wambera K, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology 2009 Jan 20;72(3):232-9. This first nation-wide prospective survey on acquired CNS demyelination in children provides important data on incidence, demographic, and clinical characteristics.
15. Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology. 2001;56 (10):1308-12. (Pubitemid 32455289)
16. Anlar B, Basaran C, Kose G, Guven A, Haspolat S, Yakut A, et al. Acute disseminated encephalomyelitis in children: Outcome and prognosis. Neuropediatrics. 2003;34(4):194-9. (Pubitemid 37152789)
17. Singhi PD, Ray M, Singhi S, Kumar KN. Acute disseminated encephalomyelitis in North Indian children: Clinical profile and follow-up. J Child Neurol. 2006;21(10):851-7. (Pubitemid 46099271)
18. Mikaeloff Y, Caridade G, Husson B, Suissa S, Tardieu M. Acute disseminated encephalomyelitis cohort study: Prognostic factors for relapse. Eur J Paediatr Neurol. 2007;11(2):90-5.
19. Mar S, Lenox J, Benzinger T, Brown S, Noetzel M. Long-term prognosis of pediatric patients with relapsing acute disseminated encephalomyelitis. J Child Neurol 2010 Jun;25(6):681-8. This is a clinically highly relevant study on the long-term prognosis of pediatric patients with ADEM, using the international Pediatric MS Study Group definitions and reporting follow-up data for a mean duration of 9 years. Of note, only 6% of children with ADEM developed MS.
20. Langer-Gould A, Zhang JL, Chung J, Yeung Y, Waubant E, Yao J. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology. 2011;77(12):1143-8.
21. VanLandingham M, Hanigan W, Vedanarayanan V, Fratkin J. An uncommon illness with a rare presentation: Neurosurgical management of ADEM with tumefactive demyelination in children. Childs Nerv Syst. 2010;26(5):655-61.
22. Richard HT, Harrison JF, Abel TW,Maertens P,Martino AM, Sosnowski JS. Pediatric gliomatosis cerebri mimicking acute disseminated encephalomyelitis. Pediatrics. 2010;126(2):e479-82.
23. Menge T, Kieseier BC, Nessler S, Hemmer B, Hartung HP, Stuve O. Acute disseminated encephalomyelitis: An acute hit against the brain. Curr Opin Neurol. 2007;20(3):247-54. (Pubitemid 46743104)
24. Collongues N, Marignier R, Zephir H, Papeix C, Fontaine B, Blanc F, et al. Long-term follow-up of neuromyelitis optica with a pediatric onset. Neurology. 2010;75(12):1084-8.
25. Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation. 2011;8(1):184.
26. Lekoubou A, Viaccoz A, Didelot A, Anastasi A, Marignier R, Ducray F, et al. Anti-N-methyl-d-aspartate receptor encephalitis with acute disseminated encephalomyelitis- like MRI features. Eur J Neurol. 2012;19(2):e16-7.
27. Borhani HA, Ashjazadeh N. Acute disseminated encephalomyelitis- like manifestations in a patient with neuro-Behcet disease. Neurologist. 2009;15(5):282-4.
28. O'Connor KC, McLaughlin KA, De Jager PL, Chitnis T, Bettelli E, Xu C, et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med. 2007;13(2):211-7.
29. Probstel AK, Dornmair K, Bittner R, Sperl P, Jenne D, Magalhaes S, et al. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology. 2011;77(6):580-8.
30. Selter RC, Brilot F, Grummel V, Kraus V, Cepok S, Dale RC, et al. Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases. Neurology. 2010;74(21):1711-5.
31. Idrissova Z, Boldyreva MN, Dekonenko EP, Malishev NA, Leontyeva IY, Martinenko IN, et al. Acute disseminated encephalomyelitis in children: Clinical features and HLA-DR linkage. Eur J Neurol. 2003;10 (5):537-46. (Pubitemid 38021469)
32. Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain. 2000;123(Pt 12):2407-22.
33. Mikaeloff Y, Suissa S, Vallee L, Lubetzki C, Ponsot G, Confavreux C, et al. First episode of acute CNS inflammatory demyelination in childhood: Prognostic factors for multiple sclerosis and disability. J Pediatr. 2004;144(2):246-52. (Pubitemid 38869403)
34. Absoud M, Parslow RC, Wassmer E, Hemingway C, Duncan HP, Cummins C, et al. Severe acute disseminated encephalomyelitis: A paediatric intensive care population-based study. Mult Scler. 2011;17 (10):1258-61.
35. Ketelslegers IA, Visser IE, Neuteboom RF, Boon M, Catsman-Berrevoets CE, Hintzen RQ. Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children. Mult Scler. 2011;17(4):441-8.
36. Samile N, Hassan T. Acute disseminated encephalomyelitis in children. A descriptive study in Tehran, Iran. Saudi Med J. 2007;28(3):396-9. (Pubitemid 46605060)
37. Sonneville R, Demeret S, Klein I, Bouadma L, Mourvillier B, Audibert J, et al. Acute disseminated encephalomyelitisin the intensive care unit:clinical features and outcome of 20 adults. Intensive Care Med. 2008;34(3):528-32. (Pubitemid 351623025)
38. Tenembaum S, Chitnis T, Ness J, Hahn JS. Acute disseminated encephalomyelitis. Neurology. 2007;68(16 Suppl 2):S23-36. (Pubitemid 46626003)
39. Atzori M, Battistella PA, Perini P, Calabrese M, Fontanin M, Laverda AM, et al. Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: A single centre prospective study. Mult Scler. 2009;15(3):363-70.
40. de Seze J, Debouverie M, Zephir H, Lebrun C, Blanc F, Bourg V, et al. Acute fulminant demyelinating disease: A descriptive study of 60 patients. Arch Neurol 2007 Oct;64(10):1426-32. (Pubitemid 47572666)
41. Callen DJ, Shroff MM, Branson HM, Li DK, Lotze T, Stephens D, et al. Role of MRI in the differentiation of ADEM from MS in children. Neurology 2009 Mar 17;72(11):968-73. This paper proposes MRI diagnostic criteria for differentiating children with ADEM from those who will later develop MS, with a sensitivity of 81% and a specificity of 95%. These criteria will hopefully enhance diagnostic accuracy at the onset of acute CNS demyelination in childhood.
42. Ketelslegers IA, Neuteboom RF, Boon M, Catsman- Berrevoets CE, Hintzen RQ. A comparison of MRI criteria for diagnosing pediatric ADEM and MS. Neurology. 2010;74(18):1412-5. This study tests the currently available sets of MRI criteria for distinguishing ADEM from MS, demonstrating that the Callen MS-ADEM criteria are the most useful, showing a sensitivity of 75% and a specificity of 95% in this pediatric Dutch cohort.
43. Jayakrishnan MP, Krishnakumar P. Clinical profile of acute disseminated encephalomyelitis in children. J Pediatr Neurosci 2010 Jul;5(2):111-4. This retrospective study compares ADEM in pediatric and adult patients, documenting that disease course and outcome of ADEM is more severe in adults.
44. Visudtibhan A, Tuntiyathorn L, Vaewpanich J, Sukjit P, Khongkatithum C, Thampratankul L, et al. Acute disseminated encephalomyelitis: A 10-year cohort study in Thai children. Eur J Paediatr Neurol. 2010;14(6):513-8.
45. Marchioni E, Tavazzi E, Minoli L, Del BS, Ferrante P, Piccolo G, et al. Acute disseminated encephalomyelitis. Neurol Sci. 2008;29 Suppl 2:S286-8.
46. McDaneld LM, Fields JD, Bourdette DN, Bhardwaj A. Immunomodulatory therapies in neurologic critical care. Neurocritical Care. 2010;12(1):132-43.
47. Sonneville R, Klein IF, Wolff M. Update on investigation and management of postinfectious encephalitis. Current Opinion In Neurology. 2010;23(3):300-4.
48. Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A. Evidence-based guideline update: Plasmapheresis in neurologic disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011;76(3):294-300.
49. Weiner HL, Dau PC, Khatri BO, Petajan JH, Birnbaum G, McQuillen MP, et al. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology. 1989;39(9):1143-9. (Pubitemid 19239712)
50. Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999;46(6):878-86.
51. Shinozaki K, Oda S, Sadahiro T, Nakamura M, Abe R, Nakamura S, et al. A case report of plasmapheresis in the treatment of acute disseminated encephalomyelitis. Ther Apher Dial. 2008;12(5):401-5.
52. Dombrowski KE, Mehta AI, Turner DA, McDonagh DL. Life-saving hemicraniectomy for fulminant acute disseminated encephalomyelitis. Br J Neurosurg. 2011;25(2):249-52.
53. Ahmed AI, Eynon CA, Kinton L, Nicoll JAR, Belli A. Decompressive craniectomy for acute disseminated encephalomyelitis. Neurocritical Care. 2010;13(3):393-5.
54. Sekula Jr RF, Marchan EM, Baghai P, Jannetta PJ, Quigley MR. Central brain herniation secondary to fulminant acute disseminated encephalomyelitis: Implications for neurosurgical management. Case report. Journal Of Neurosurgery. 2006;105 (3):472-4. (Pubitemid 44358762)
55. von Stuckrad-Barre S, Klippel E, Foerch C, Lang JM, du Mesnil de RR, Sitzer M. Hemicraniectomy as a successful treatment of mass effect in acute disseminated encephalomyelitis. Neurology. 2003;61 (3):420-1. (Pubitemid 36975986)
56. Takata T, Hirakawa M, Sakurai M, Kanazawa I. Fulminant form of acute disseminated encephalomyelitis: Successful treatmentwith hypothermia. Journal Of The Neurological Sciences. 1999;165(1):94-7. (Pubitemid 29298089)
57. Leake JA, Billman GF, Nespeca MP, Duthie SE, Dory CE, Meltzer HS, et al. Pediatric acute hemorrhagic leukoencephalitis: Report of a surviving patient and review. Clin Infect Dis. 2002;34(5):699-703. (Pubitemid 34165335)
58. Payne ET, Rutka JT, Ho TK, Halliday WC, Banwell BL. Treatment leading to dramatic recovery in acute hemorrhagic leukoencephalitis. J Child Neurol. 2007;22(1):109-13. (Pubitemid 46860451)
59. Pradhan S, Gupta RP, Shashank S, Pandey N. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci. 1999;165 (1):56-61. (Pubitemid 29298082)
60. Nishikawa M, Ichiyama T, Hayashi T, Ouchi K, Furukawa S. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. Pediatr Neurol. 1999;21(2):583-6. (Pubitemid 29366831)
61. Gupte G, Stonehouse M, Wassmer E, Coad NA, Whitehouse WP. Acute disseminated encephalomyelitis: A review of 18 cases in childhood. J Paediatr Child Health. 2003;39(5):336-42. (Pubitemid 37072231)
62. Khurana DS, Melvin JJ, Kothare SV, Valencia I, Hardison HH, Yum S, et al. Acute disseminated encephalomyelitis in children: Discordant neurologic and neuroimaging abnormalities and response to plasmapheresis. Pediatrics. 2005;116(2):431-6. (Pubitemid 44161470)
63. Pavone P, Pettoello-Mantovano M, Le PA, Giardino I, Pulvirenti A, Giugno R, et al. Acute disseminated encephalomyelitis: A long-term prospective study and meta-analysis. Neuropediatrics 2010 Dec;41 (6):246-55. This is a single-center case series, systematic review, and meta-analysis of 15 previously published pediatric ADEM cohorts, comprising 750 patients.
64. Panicker JN, Nagaraja D, Kovoor JM, Subbakrishna DK. Descriptive study of acute disseminated encephalomyelitis and evaluation of functional outcome predictors. J Postgrad Med. 2010;56(1):12-6.
65. Pasternak JF, De V, Prensky AL. Steroid-responsive encephalomyelitis in childhood. Neurology. 1980;30 (5):481-6. (Pubitemid 10112800)
66. Murthy JM, Yangala R, Meena AK, Jaganmohan RJ. Acute disseminated encephalomyelitis: Clinical and MRI study from South India. J Neurol Sci. 1999;165 (2):133-8. (Pubitemid 29329512)
67. Hung KL, Liao HT, Tsai ML. The spectrum of postinfectious encephalomyelitis. Brain Dev. 2001;23 (1):42-5.
68. Murthy SN, Faden HS, Cohen ME, Bakshi R. Acute disseminated encephalomyelitis in children. Pediatrics. 2002;110(2 Pt 1):e21.
69. Shahar E, Andraus J, Savitzki D, Pilar G, Zelnik N. Outcome of severe encephalomyelitis in children: Effect of high-dose methylprednisolone and immunoglobulins. J Child Neurol. 2002;17(11):810-4. (Pubitemid 36193070)
70. Brass SD, Caramanos Z, Santos C, Dilenge ME, Lapierre Y, Rosenblatt B. Multiple sclerosis vs acute disseminated encephalomyelitis in childhood. Pediatr Neurol. 2003;29(3):227-31. (Pubitemid 37415255)
71. Suppiej A, Vittorini R, Fontanin M, De GD, Manara R, Atzori M, et al. Acute disseminated encephalomyelitis in children: Focus on relapsing patients. PediatrNeurol. 2008;39(1):12-7. (Pubitemid 351794413)
72. Jacobs RK, Anderson VA, Neale JL, Shield LK, Kornberg AJ. Neuropsychological outcome after acute disseminated encephalomyelitis: Impact of age at illness onset. Pediatr Neurol. 2004;31(3):191-7. (Pubitemid 39221245)
73. Dundar NO, Anlar B, Guven A, Serdaroglu A, Yarar C. Relapsing acute disseminated encephalomyelitis in children: Further evaluation of the diagnosis. J Child Neurol. 2010;25(12):1491-7.
74. Banwell B, Bar-Or A, Arnold DL, Sadovnick D, Narayanan S, McGowan M, et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: A prospective national cohort study. Lancet Neurol. 2011;10(5):436-45.
75. Budan B, Ekici B, Tatli B, Somer A. Acute disseminated encephalomyelitis (ADEM) after pertussis infection. Ann Trop Paediatr. 2011;31(3):269-72.
76. Tosun A, Serdaroglu G, Polat M, Tekgul H, Gokben S. Evaluation of the cases with acute disseminated encephalomyelitis. Indian J Pediatr. 2009;76 (5):547-50.
77. Van Dam CN, Syed S, Eron JJ, Ostrander M, Engler RJM, Damon I, et al. Severe postvaccinia encephalitis with acute disseminated encephalomyelitis: Recovery with early intravenous immunoglobulin, high-dose steroids, and vaccinia immunoglobulin. Clinical Infectious Diseases: An Official Publication Of The Infectious Diseases Society Of America. 2009;48(4): E47-9.
78. Ravaglia S, Piccolo G, Ceroni M, Franciotta D, Pichiecchio A, Bastianello S, et al. Severe steroidresistant post-infectious encephalomyelitis: General features and effects of IVIg. Journal Of Neurology. 2007;254(11):1518-23. (Pubitemid 350159893)
79. Bangsgaard R, Larsen VA, Milea D. Isolated bilateral optic neuritis in acute disseminated encephalomyelitis. Acta Ophthalmol Scand. 2006;84(6):815-7. (Pubitemid 44688334)
80. Weng WC, Peng SS, Lee WT, Fan PC, Chien YH, Du JC, et al. Acute disseminated encephalomyelitis in children: One medical center experience. Acta Paediatr Taiwan. 2006;47(2):67-71.
81. Lu RP, Keilson G. Combination regimen of methylprednisolone, IV immunoglobulin, and plasmapheresis early in the treatment of acute disseminated encephalomyelitis. Journal Of Clinical Apheresis. 2006;21(4):260-5. (Pubitemid 46034442)
82. Kanaheswari Y, Baizura J, Paeds M, Zulfiqar A. Intravenous immunoglobulin in the treatment of acute disseminated encephalomyelitis. Med J Malaysia. 2004;59(1):103-7.
83. Marchioni E, Marinou-Aktipi K, Uggetti C, Bottanelli M, Pichiecchio A, Soragna D, et al. Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. Journal of Neurology. 2002;249(1):100-4. (Pubitemid 34126395)
84. Pittock SJ, Keir G, Alexander M, Brennan P, Hardiman O. Rapid clinical and CSF response to intravenous gamma globulin in acute disseminated encephalomyelitis. Eur J Neurol. 2001;8(6):725. (Pubitemid 35015243)
85. Straussberg R, Schonfeld T, Weitz R, Karmazyn B, Harel L. Improvement of atypical acute disseminated encephalomyelitis with steroids and intravenous immunoglobulins. Pediatr Neurol. 2001;24 (2):139-43. (Pubitemid 32280298)
86. Andersen JB, Rasmussen LH, Herning M, Paerregaard A. Dramatic improvement of severe acute disseminated encephalomyelitis after treatment with intravenous immunoglobulin in a three-year-old boy. Dev Med Child Neurol. 2001;43(2):136-8. (Pubitemid 32170857)
87. Sahlas DJ, Miller SP, Guerin M, Veilleux M, Francis G. Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology. 2000;54(6):1370-2. (Pubitemid 30174062)
88. Finsterer J, Grass R, Stöllberger C, Mamoli B. Immunoglobulins in acute, parainfectious, disseminated encephalo-myelitis. Clin Neuropharmacol. 1998;21(4):258-61. (Pubitemid 28367081)
89. Schroder A, Linker RA, Gold R. Plasmapheresis for neuroinflammatory disorders. Clinical and Experimental Neuroimmunology. 2010;1(3):95- 102.
90. RamachandranNair R, Rafeequ M, Girija AS. Plasmapheresis in childhood acute disseminated encephalomyelitis. Indian Pediatr. 2005;42 (5):479-82. (Pubitemid 40732913)
91. Ryan LJ, Bowman R, Zantek ND, Sherr G, Maxwell R, Clark HB, et al. Use of therapeutic plasma exchange in the management of acute hemorrhagic leukoencephalitis: A case report and review of the literature. Transfusion. 2007;47(6):981-6. (Pubitemid 46802080)
92. Llufriu S, Castillo J, Blanco Y, Ramio-Torrenta L, Rio J, Valles M, et al. Plasma exchange for acute attacks of CNS demyelination: Predictors of im- provement at 6 months. Neurology. 2009;73 (12):949-53.
93. Yucesan C, Arslan O, Arat M, Yucemen N, Ayyildiz E, Ilhan O, et al. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: Review of 50 cases. Transfus Apher Sci. 2007;36 (1):103-7. (Pubitemid 46341969)
94. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: Predictors of response. Neurology. 2002;58(1):143-6.
95. RamachandranNair R, Parameswaran M, Girija AS. Acute disseminated encephalomyelitis treated with plasmapheresis. Singapore Med J. 2005;46 (10):561-3. (Pubitemid 41406524)
96. Ham HY, Lee JK, Jang JW, Seo BR, Kim JH, Choi JW. Post-traumatic cerebral infarction: Outcome after decompressive hemicraniectomy for the treatment of traumatic brain injury. J Korean Neurosurg Soc. 2011;50(4):370-6.
97. Parrish JB, Weinstock-Guttman B, Yeh EA. Cerebellar mutism in pediatric acute disseminated encephalomyelitis. Pediatr Neurol. 2010;42(4):259-66.
98. Axer H, Ragoschke-Schumm A, Bottcher J, Fitzek C, Witte OW, Isenmann S. Initial DWI and ADC imaging may predict outcome in acute disseminated encephalomyelitis: Report of two cases of brain stem encephalitis. JNeurolNeurosurg Psychiatry. 2005;76(7):996-8. (Pubitemid 40909561)
99. Makhani N, Gorman MP, Branson HM, Stazzone L, Banwell BL, Chitnis T. Cyclophosphamide therapy in pediatric multiple sclerosis. Neurology. 2009;72 (24):2076-82.
100. Greenberg BM, Thomas KP, Krishnan C, Kaplin AI, Calabresi PA, Kerr DA. Idiopathic transverse myelitis: Corticosteroids, plasma exchange, or cyclophosphamide. Neurology. 2007;68(19):1614-7. (Pubitemid 46717987)